| GlaxoSmithKline AG - Omjjara 150 mg, Filmtabletten | | 69428 | | 02 | | Omjjara 150 mg | | Filmtabletten | | L01EJ04 | | | | 25.09.2024 | | |
| | Composition | | momelotinibum 150 mg ut momelotinibi dihydrochloridum monohydricum, cellulosum microcristallinum, lactosum monohydricum 76.14 mg, carboxymethylamylum natricum A, magnesii stearas, silica colloidalis anhydrica, E 310, Überzug: poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.13 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Momelotinibum | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Momelotinibum | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | E 310 | | | | Lactose Monohydrate | 76.14 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 | 4009.10 | 4376.55 | A | LS | Non |
|
|
